What Has Been the Growth of the Monkey Pox Treatment Market So Far?
The monkey pox treatment market has seen considerable growth due to a variety of factors.
• The monkeypox treatment market has seen rapid growth in recent years. It is expected to rise from $0.09 billion in 2024 to $0.1 billion in 2025, reflecting a CAGR of 13.6%.
The increase is due to outbreaks in endemic regions, greater awareness of zoonotic transmission, the legacy of smallpox eradication, public health initiatives, and the emergence of human cases.
How Will the Monkey Pox Treatment Market?
The monkey pox treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The monkey pox treatment market is expected to reach $0.17 billion by 2029 at a CAGR of 13.3%.
Growth is driven by globalization, government funding, biotech investment, public health surveillance, and regulatory approvals. Trends include antiviral drug development, the use of smallpox vaccines, monoclonal antibodies, combination therapies, and research into long-term immunity.
Which Factors Are Boosting Growth In The Monkey Pox Treatment Market?
The increasing prevalence of zoonotic infections is expected to drive the growth of the monkeypox treatment market. Zoonotic infections are diseases transmitted from animals to humans, and factors such as increased human-animal interaction and climate change are raising the risk of these infections. Monkeypox treatments are essential for managing infections by targeting the virus and alleviating symptoms in both humans and animals. For instance, the UK Health Security Agency reported 3,732 confirmed monkeypox cases in the UK in 2023, rising from 3,753 in 2022. This increasing prevalence of zoonotic infections is driving the growth of the monkeypox treatment market.
What Key Areas Define The Segmentation Of The Global Monkey Pox Treatment Market?
The monkey pox treatment market covered in this report is segmented –
1) By Treatment Type: Prophylactic Vaccines, Therapeutics
2) By Dosage Forms: Solid, Liquid, Semi Solid
3) By Route Of Administration: Oral, Topical, Parenteral
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Prophylactic Vaccines: Vaccinia-Based Vaccines, Modified Vaccinia Ankara (MVA) Vaccines, Other Vaccines (Recombinant Vaccines)
2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir), Immune Modulators, Supportive Care Treatments
Pre-Book The Monkey Pox Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Monkey Pox Treatment Market?
Leading firms in the monkeypox treatment industry have shifted their focus towards remote supervision and teletherapy solutions like virtual care. This shift seeks to boost accessibility, simplify the management process, and enhance the effectiveness of the treatment plan. The deployment of virtual care in monkeypox treatment involves strategies such as virtual doctor consultations, symptom examination, and treatment proposals for both at-risk and infected persons. This approach minimizes the need for physical appointments. A clear example of this was in August 2022 when Folx Health, a healthcare organization based in the US, rolled out Monkeypox Care. This is a virtual primary care service specifically designed for individuals who may be at risk of or have contracted monkeypox. The strategy is comprehensive and includes elements like education, counseling, symptom examination, and referrals. This pioneering initiative aims at reaching inhabitants of care deserts – zones with restricted healthcare access, thus ensuring that all individuals, irrespective of their location, can access quality information and referrals.
Who Are the Key Players In The Monkey Pox Treatment Market?
Major companies operating in the monkey pox treatment market are:
• Roche Holding AG
• Merck & Co. Inc.
• Sanofi S.A.
• Gilead Sciences Inc.
• BioNTech SE
• Moderna Inc.
• Quest Diagnostics Incorporated
• Novavax Inc.
• Laboratory Corporation of America Holdings
• Emergent BioSolutions Inc.
• Bavarian Nordic A/S
• Aegis Sciences Corporation
• Daan Gene Co. Ltd.
• Sansure Biotech Inc.
• SIGA Technologies Inc.
• Elabscience Biotechnology Inc.
• Mayo Clinic Laboratories
• Tonix Pharmaceuticals Holding Corp.
• Altona Diagnostics GmbH
• Lansion Biotechnology Co. Ltd.
• Goldsite Diagnostics Inc.
• Chimerix Inc.
• Emcure Pharmaceuticals Ltd.
• VBI Vaccines Inc
What Is The Most Dominant Region In The Monkey Pox Treatment Market?
North America was the largest region in the monkey pox treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
